Polymeric antigen BLSOmp31 formulated with class B CpG-ODN in a nanostructure (BLSOmp31/CpG-ODN/Coa-ASC16) administered by parenteral or mucosal routes confers protection against Brucella ovis in Balb/c mice
María Celeste Morán, Ángel Ricardo Bence, María F. Sánchez Vallecillo, Claudia Lützelschwab, Marcelo Gastón Rodriguez, Romina Pardo, Fernando A. Goldbaum, Vanesa Zylberman, Santiago Daniel Palma, Belkys Maletto, Silvia M. Estein
Topics & Concepts
CpG OligodeoxynucleotideAdjuvantImmunologyImmune systemAntibodyAntigenBALB/cNasal administrationMedicineChemistryBiochemistryGeneGene expressionDNA methylationBrucella: diagnosis, epidemiology, treatmentImmunotherapy and Immune ResponsesEscherichia coli research studies